Every September 26th and the days leading up to it, the Mesothelioma Applied Research Foundation, its community and allies, place extra focus on raising awareness of this cancer, the obstacles to research into life-saving treatments, and the lives of those affected and their families. This year’s campaign once again centers around painting the world blue […]
On Satuday, September 9, 2017, at 9:30 am, a truly spectacular occurrence can be witnessed within the banks of the Hudson river: Hundreds of kayakers will descend down the river from Stillwater, NY to Halfmoon, NY to raise awareness and funds for mesothelioma research, education, support, and advocacy. This 8-mile paddle takes between 3 and […]
“I spent 20 years trying to do immunotherapy and we weren’t as successful as we wanted to be probably because we didn’t recognize the degree to which the environment within the tumor is so suppressive,” said Dr. Dan Sterman during our latest Meet the Mesothelioma Experts broadcast referring to the inability of the immune system […]
At the end of October of 2017, Dr. H. Richard Alexander, esteemed surgeon specializing in peritoneal mesothelioma, will be moving from his current institution, the University of Maryland, to Rutgers University in New Jersey. His new position as Chief Surgical Officer will combine administrative as well as clinical duties. As such, Dr. Alexander will also […]
In a statement released on Sunday, Bayer announced that Anetumab ravtansine, its antibody-drug conjugate (ADC) tested in mesothelioma, has missed its primary endpoint failing to improve progression-free survival in mesothelioma patients.
“Malignant pleural mesothelioma is a very difficult-to-treat tumor, and we had hoped for a better outcome for patients,” said Robert LaCaze, Executive Vice President and […]